RT Journal
A1 Sox HC
T1 SCreening for lung cancer with chest radiographs
JF JAMA
JO JAMA
YR 2011
FD November 2
VO 306
IS 17
SP 1916
OP 1918
DO 10.1001/jama.2011.1609
UL http://dx.doi.org/10.1001/jama.2011.1609
AB 
Within the space of several months, 2 very large randomized trials of screening for lung cancer have reported their findings, which fortunately complement one another. The National Lung Screening Trial (NLST) found that annual low-dose computed tomography (CT) reduced lung cancer mortality by 20% relative to annual chest radiography.1 In this issue of JAMA, investigators from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Randomized Trial report that annual screening chest radiography does not reduce lung cancer mortality relative to no screening.2 Should clinicians infer that screening with low-dose CT reduces lung cancer mortality by 20% relative to no screening? This editorial addresses that question and several other aspects of the PLCO trial.